Hem › Sickelcellssjukdom › District of Columbia
Kliniska studier för Sickelcellssjukdom i District of Columbia
10 studier för Sickelcellssjukdom söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
RekryterarObservationsstudie
Ålder 4 till 65 · Alla kön · Uppdaterad 27 juli 2026 · NCT05153967Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's National Hospital (MRD-HCT), Washington D.C.
RekryterarObservationsstudie
Ålder 3 till 20 · Alla kön · Uppdaterad 4 juni 2026 · NCT06941389Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
RekryterarFas 2
Ålder 4 till 21 · Alla kön · Uppdaterad 13 apr. 2026 · NCT06635902Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Children's National Health System, Washington D.C.
RekryterarFas 2
Ålder 2 till 25 · Alla kön · Uppdaterad 10 mars 2026 · NCT03587272Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- Children's National Hospital, Washington D.C.
RekryterarFas 2
Ålder 2 till 25 · Alla kön · Uppdaterad 26 sep. 2025 · NCT06358638Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Rekryterar
Ålder 7 till 16 · Alla kön · Uppdaterad 13 feb. 2025 · NCT06770010Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Rekryterar
Ålder 8 till 16 · Alla kön · Uppdaterad 10 jan. 2025 · NCT05099874Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.